Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease
Clinical trial NCT03295786 · COMPLETED
Trial details
- NCT number
- NCT03295786
- Sponsor
- Herantis Pharma Plc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-26
- Primary completion
- 2019-12-19
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.